» Articles » PMID: 33773923

Vaccines - Safety in Pregnancy

Overview
Publisher Elsevier
Date 2021 Mar 28
PMID 33773923
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccination during pregnancy is important for active immunity of the mother against serious infectious diseases, and also for passive immunity of the neonate to infectious diseases with high morbidity and mortality. As a rule, live vaccines are contraindicated during pregnancy as they may cause fetal viremia/bacteremia. Inactivated vaccines are generally safe. Vaccines safe to be administered to all pregnant ladies are tetanus toxoid (TT; tetanus, diphtheria, acellular pertussis (Tdap) and Flu vaccines. During pre-pregnancy counselling, vaccination for MMR (measles, mumps, and rubella) should be offered, with an advice to avoid pregnancy for a month. All pregnant mothers should receive TT and Tdap vaccination during the third trimester. Flu vaccine can be given to all mothers at any gestation, and if not offered during pregnancy, it can be given postpartum. Vaccinations that should be offered to women if at high risk of exposure are for hepatitis A and B, pneumococcal, meningococcal, yellow fever, Japanese encephalitis (JE), polio, typhoid, and cholera infections. Vaccines to be given only for post-exposure prophylaxis (PEP) are smallpox, rabies, and anthrax. Postpartum women should be offered human papillomavirus (HPV) vaccination. If not immunized earlier, they should be offered MMR, Tdap, and Flu vaccines. Future vaccines being developed are for malaria, Zika virus, respiratory syncytial virus (RSV), group B streptococcus, CMV, and COVID-19 (SARS-Cov-2).

Citing Articles

Safety and Efficacy of Vaccines During Pregnancy: A Systematic Review.

Chittajallu L, Kaku R, Kondadasula P, Lim J, Zhumabekova A Cureus. 2025; 17(1):e77176.

PMID: 39925513 PMC: 11806401. DOI: 10.7759/cureus.77176.


Exploring How Adipose Tissue, Obesity, and Gender Influence the Immune Response to Vaccines: A Comprehensive Narrative Review.

De Sanctis J, Balda Noria G, Garcia A Int J Mol Sci. 2025; 26(2).

PMID: 39859575 PMC: 11765591. DOI: 10.3390/ijms26020862.


Effect of SpikoGen subunit vaccine administration during pregnancy on fetal development of rats.

Aghsami M, Aljoiber H, Mirfendereski S, Mottaghi-Dastjerdi N, Soltani J, Aslani H Clin Exp Vaccine Res. 2024; 13(4):301-308.

PMID: 39525669 PMC: 11543795. DOI: 10.7774/cevr.2024.13.4.301.


Maternal Vaccination for the Prevention of Infantile RSV Disease: An Overview of the Authorized, In-Progress, and Rejected Vaccine Candidates.

Papazisis G, Topalidou X Vaccines (Basel). 2024; 12(9).

PMID: 39340012 PMC: 11435746. DOI: 10.3390/vaccines12090980.


Synergistic Effect of Maternal Micronutrient Supplementation on ORFV DNA Vaccine Immune Response in a Pregnant Model.

Ahmed S, Liu G, Sadiq A, Yang H, Yongbin L, Farooq U Biol Trace Elem Res. 2024; 203(3):1582-1599.

PMID: 38874865 DOI: 10.1007/s12011-024-04263-9.


References
1.
Faucette A, Unger B, Gonik B, Chen K . Maternal vaccination: moving the science forward. Hum Reprod Update. 2014; 21(1):119-35. PMC: 4255605. DOI: 10.1093/humupd/dmu041. View

2.
Chaudhry S, Koren G . Hepatitis A infection during pregnancy. Can Fam Physician. 2016; 61(11):963-4. PMC: 4642904. View

3.
Herberts C, Melgert B, van der Laan J, Faas M . New adjuvanted vaccines in pregnancy: what is known about their safety?. Expert Rev Vaccines. 2010; 9(12):1411-22. DOI: 10.1586/erv.10.133. View

4.
Zhu F, Guan X, Li Y, Huang J, Jiang T, Hou L . Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020; 396(10249):479-488. PMC: 7836858. DOI: 10.1016/S0140-6736(20)31605-6. View

5.
Jones C, Calvert A, Le Doare K . Vaccination in Pregnancy-Recent Developments. Pediatr Infect Dis J. 2017; 37(2):191-193. DOI: 10.1097/INF.0000000000001822. View